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Objectives: Orai3 is a store-operated Ca2+ channel speciﬁc for mammals. Previous
studies found that 2-APB, an agonist of Orai3 channel, can either cause or prevent
atrial ﬁbrillation in animals. The aim of this study is to determine whether Orai3
mutation is a pathogenetic factor of atrial ﬁbrillation.
Methods: Genomic DNA was extracted from the peripheral blood of 124 patients
with atrial ﬁbrillation. The two exons of Orai3 gene were separately ampliﬁed from
the genomic DNA and sequenced with corresponding primers. The coding sequences
were assembled and aligned with the reference sequence from GenBank. Mutation
found in the alignment was conﬁrmed by manual check on the original sequencing
chromatograms.
Results: Two of the 124 patients were found to carry heterogenic mutation from C to
T at position 711 of the nucleic acid sequence. However, this mutation does not lead to
any change on translated amino acid sequence.
Conclusions: Due to the lack of non-synonymous mutation in Orai3 gene, we
conclude that Orai3 channel is probably not directly involved in the cardiac action
potential. The effect of 2-APB on atrial ﬁbrillation is more likely related to other
targets of this drug, such as IP3 receptors.
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Objectives: To identify gene mutations of potassium channels that contributed to the
pathogenesis of atrial ﬁbrillation.
Methods: Genomic DNA was extracted from the peripheral blood of 124 patients
with atrial ﬁbrillation. The coding regions of genes including KCNE1 (minK),
KCNE1L (KCNE5), KCNE2 (MiRP1), KCNE4 (MiRP3), KCNJ2 (Kir2.1) and
KCNJ4 (Kir2.3) were ampliﬁed from the genomic DNA and sequenced with corre-
sponding primers. The obtained sequences were aligned with reference sequences
from GenBank. Mutations found in the alignments were conﬁrmed by manual check
on the original sequencing chromatograms.
Results: Mutations leading to changes of amino acids and corresponding mutation
rates were found: KCNE1, S37R (0.8%), S38G (92.7%), D85N (0.8%); KCNE1L,
Y81H (0.16%); KCNE2, none; KCNE4, M109V (0.8%), D196E (91.1%); KCNJ2,
V93I (0.8%); KCNJ4, none.
Conclusions: Genetic mutations on potassium channels are important pathogenetic
factors of atrial ﬁbrillation. Among the six genes screened KCNE1 and KCNE4
showed highest mutation rates. The electrophysiological functionality of these mutants
needs to be examined in the future to understand their impacts to the cardiac action
potential.
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Objectives: To determine the effects of DS-201 on electrical remodeling of canine
and cell membrane potassium ion channels.
Methods: Mongol canines were used for preparation of animal models with AF
through rapid pacing left atrial appendage, and then the effect of DS-201 on AF was
determined by frequency and duration of AF. And Kv1.5 protein expression in atrial
myocytes was detected with western blotting.
Results: It was showed that DS-201 signiﬁcantly reduced both the frequency and
duration of AF (P<0.05, n¼5). The frequency of AF was reduced from 7.21.31 to
3.121.05, and the duration of AF was lowered from 5.22.13 s to 0.891.23 s. It is
interested that DS-201 did not inhibit Kv1.5 protein expression but signiﬁcantly in-
crease its expression.
Conclusions: DS-201 improves tachycardia-induced electrical remodeling of canine
by meliorating the low-level expression of Kv1.5 in AF.
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Objectives: Sodium tanshinone IIA sulfonate (STS) is a water-soluble derivative of
tanshinone IIA, the major lipophilic component extracted from the root of Danshen
(Salvia Miltiorrhiza). STS is clinically used in the treatment of myocardial infarction,
coronary artery disease and other cardiovascular disorders. STS can protect the heart
against pathological hypertrophy in laboratory animals. However, the direct molecular
targets of STS on cardiomyocytes are still unclear. Here we aim to examine the effect
of STS on the activity of TRPC channels, which have been suggested to be important
mediators of pathological cardiac hypertrophy.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BMethods: Intracellular Ca2+ measurement and patch clamp recordings were per-
formed on HEK293 cells stably transfected with human TRPC4 and TRPC5 cDNA.
STS was applied to the extracellular solution to test the drug effect.
Results: We found that STS at micromolar concentrations inhibited TRPC4 and
TRPC5 channels. The potency of tanshinone IIA on the inhibition of these channels is
much lower than that of STS, suggesting the sulfonation of this compound is
important for its channel-inhibitory activity.
Conclusions: The inhibition of TRPC channels by STS found in this study is a novel
aspect of the cardioprotective pharmacology of this drug. As STS has been used in
patients by injection with safety approval, our results suggest that blockade of TRPC
channels is a potentially safe strategy for clinical therapy.
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Objectives: The objective of this study was to investigate whether monoclonal
autoantibodies against the second extracellular loop of b1-adrenergic receptor (b1-AR
mAb) induce directly ventricular arrhythmias and to clarify the electrophysiologic
mechanisms.
Methods: To identify the function of b1-AR mAb, the binding of b1-AR mAb with
the b1-adrenergic receptor (b1-AR) on the H9C2 by laser scanning confocal micro-
scopy and the effects of b1-AR mAb on the beat frequency in cultured ventricular
myocytes of neonatal rats were observed. A langendorff perfused heart model was
used in this study to explore the direct roles of b1-AR mAb in arrhythmias.
Results: Results showed that b1-AR mAb may bind with b1-AR and increase the beat
frequency of ventricular myocytes of neonatal rats, which was similar to autoanti-
bodies against the second extracellular loop of b1-adrenergic receptor (b1-AA) isolated
from patients, thus b1-AR mAb might be seen as the tool to stuy b1-AA. b1-AR mAb
induced ventricular premature contractions, and enhanced the excitability of ventric-
ular ﬁbrillation by decreasing the threshold of ventricular ﬁbrillation (b1-AR mAb
group: 9.01.5 V; Control group: 11.02.1 V, P<0.05, n¼5/group) and prolonging
the duration of ventricular ﬁbrillation (b1-AR mAb group: 1608.0135.0 ms; Control
group: 1000.0127.1 ms, P<0.05, n¼5/group); b1-AR mAb increased the suscepti-
bility to ventricular arrhythmias as a result of repolarization abnormalities by reducing
corrected QT intervals (0 min: 360.011.1 ms; 10 min: 333.014.0 ms, P<0.05,
n¼5/group) and prolonging late phase repolarization of monophasic action (MAPD90-30)
(0 min: 360.011.1 ms; 10 min: 333.014.0 ms, P<0.05, n¼5/group) in isolated
guinea pig hearts.
Conclusions: It is concluded that b1-AR mAb could induce directly ventricular
arrhythmias attributed to the increase of the susceptibility of ventricular arrhythmias
by causing repolarization abnormalities.
GW25-e3301
Cardioprotective Effect of Pinacidil on Rats Heart with Transient Hypoxia and
Reperfusion Injury
Zhu Fen, Xiaoyan Dong
Department of Cardiology, Wuhan University School of Medicine Afﬁliated Tongren
Hospital, Wuhan, China
Objectives: The aim of this study was to evaluate the cardioprotective effect of
pinacidil postconditioning on rat hearts with transient hypoxia and reperfusion.
Methods: An acute myocardial anoxia-reperfusion rat model was created by ligating
coronary arteries for 10 min and subsequent reperfusion for 60 min. Twenty-four rats
in 4 groups received different treatments: normal hearts as control (N¼6), anoxia-
reperfusion (A/R) only (N¼6), pinacidil postconditioning (N¼6), and pinacidil plus
adenosine triphosphate-sensitive potassium channel inhibitors (glibenclamide) (N¼6).
The kinetic parameters and electrophysiological properties, including early apoptosis
protein expression changes of Bax, Bcl-2, and FN were examined using the isolated
perfusion and patch-clamp technique and immunohistochemistry.
Results: The left ventricular systolic pressure and maximum -dp/dt in A/R groups
were signiﬁcantly higher than those in the control group (P<0.05). The left ventricular
developing pressure, maximum +dp/dt, and heart rate in the A/R group were slightly
decreased. The pinacidil-postconditioned group has better cardiac function recovery
after ischemia/reperfusion than the A/R group (P<0.01). In addition, using the patch-
clamp technique, signiﬁcant differences in the mean open time and conductance value
were found in the pinacidil group relative to the A/R group. The expression of
apoptosis proteins (Bax, FN) increased during A/R, while the Bcl-2 protein expression
decreased. A signiﬁcant difference was found in the pinacidil treatment group relative
to the A/R group.
Conclusions: Pinacidil postconditioning can exert cardioprotective effects on
A/R-injured rat hearts, which may indicate a potential application of pinacidil post-
conditioning to protect A/R-injured hearts.asic and Translational Medicine C41
